Yunzhang Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yunzhang Zhao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Caizhi Liu
State Key Laboratory of Space Medicine Fundamentals and Application China Astronaut Research and Training Center Beijing China
1 shared publication - Dengchao Cao
Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892
1 shared publication - Dingsheng Zhao
State Key Laboratory of Space Medicine Fundamentals and Application China Astronaut Research and Training Center Beijing China
1 shared publication - Feng Gao
Key Laboratory of Aerospace Medicine of the Ministry of Education, School of Aerospace Medicine, Fourth Military Medical University, Xi’an, China
1 shared publication - Guanghan Kan
China Astronaut Research and Training Center, Beijing 100094, China
1 shared publication - Guohui Zhong
National Key Laboratory of Space Medicine China Astronaut Research and Training Center Beijing China
1 shared publication
Latest Publications
- 15 December 2023
- Published by Wiley in The FASEB Journal
- Vol. 38 (1) , e23369
Vascular smooth muscle cell‐specific miRNA‐214 deficiency alleviates simulated microgravity‐induced vascular remodeling
The human cardiovascular system has evolved to accommodate the gravity of Earth. Microgravity during spaceflight has been shown to induce vascular remodeling, leading to a decline in vascular function. The underlying mechanisms are not yet fully understood. Our previous study demonstrated that miR‐214 plays a critical role in angiotensin II‐induced vascular remodeling by reducing the levels of Smad7 and increasing the phosphorylation of Smad3. However, its role in vascular remodeling evoked by microgravity is not yet known. This study aimed to determine the contribution of miR‐214 to the regulation of microgravity‐induced vascular remodeling. The results of our study revealed that miR‐214 expression was increased in the forebody arteries of both mice and monkeys after simulated microgravity treatment. In vitro, rotation‐simulated microgravity‐induced VSMC migration, hypertrophy, fibrosis, and inflammation were repressed by miR‐214 knockout (KO) in VSMCs. Additionally, miR‐214 KO increased the level of Smad7 and decreased the phosphorylation of Smad3, leading to a decrease in downstream gene expression. Furthermore, miR‐214 cKO protected against simulated microgravity induced the decline in aorta function and the increase in stiffness. Histological analysis showed that miR‐214 cKO inhibited the increases in vascular medial thickness that occurred after simulated microgravity treatment. Altogether, these results demonstrate that miR‐214 has potential as a therapeutic target for the treatment of vascular remodeling caused by simulated microgravity.
- 15 December 2023
- Published by Wiley in The FASEB Journal
- Vol. 38 (1) , e23369
Vascular smooth muscle cell‐specific miRNA‐214 deficiency alleviates simulated microgravity‐induced vascular remodeling
The human cardiovascular system has evolved to accommodate the gravity of Earth. Microgravity during spaceflight has been shown to induce vascular remodeling, leading to a decline in vascular function. The underlying mechanisms are not yet fully understood. Our previous study demonstrated that miR‐214 plays a critical role in angiotensin II‐induced vascular remodeling by reducing the levels of Smad7 and increasing the phosphorylation of Smad3. However, its role in vascular remodeling evoked by microgravity is not yet known. This study aimed to determine the contribution of miR‐214 to the regulation of microgravity‐induced vascular remodeling. The results of our study revealed that miR‐214 expression was increased in the forebody arteries of both mice and monkeys after simulated microgravity treatment. In vitro, rotation‐simulated microgravity‐induced VSMC migration, hypertrophy, fibrosis, and inflammation were repressed by miR‐214 knockout (KO) in VSMCs. Additionally, miR‐214 KO increased the level of Smad7 and decreased the phosphorylation of Smad3, leading to a decrease in downstream gene expression. Furthermore, miR‐214 cKO protected against simulated microgravity induced the decline in aorta function and the increase in stiffness. Histological analysis showed that miR‐214 cKO inhibited the increases in vascular medial thickness that occurred after simulated microgravity treatment. Altogether, these results demonstrate that miR‐214 has potential as a therapeutic target for the treatment of vascular remodeling caused by simulated microgravity.